AVDL
Avadel Pharmaceuticals
AVDL
AVDL
56 hedge funds and large institutions have $211M invested in Avadel Pharmaceuticals in 2020 Q1 according to their latest regulatory filings, with 25 funds opening new positions, 7 increasing their positions, 15 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
33% more funds holding
Funds holding: 42 → 56 (+14)
22.5% more ownership
Funds ownership: 49.08% → 71.59% (+23%)
53% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 15
Holders
56
Holding in Top 10
4
Calls
$29.6M
Puts
$3.62M
Top Buyers
| 1 | +$34.7M | |
| 2 | +$28.4M | |
| 3 | +$10.8M | |
| 4 |
RI
RTW Investments
New York
|
+$9.54M |
| 5 |
ACP
Acuta Capital Partners
Redwood City,
California
|
+$8.22M |
Top Sellers
| 1 | -$16M | |
| 2 | -$13.8M | |
| 3 | -$4.71M | |
| 4 |
Morgan Stanley
New York
|
-$4.47M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$2.22M |